Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).
Identifieur interne : 001660 ( PubMed/Corpus ); précédent : 001659; suivant : 001661Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).
Auteurs : Seiichi Sakamoto ; Hiroyuki Tanaka ; Satoshi MorimotoSource :
- Annals of translational medicine [ 2305-5839 ] ; 2015.
DOI: 10.3978/j.issn.2305-5839.2015.01.15
PubMed: 25815296
Links to Exploration step
pubmed:25815296Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).</title>
<author><name sortKey="Sakamoto, Seiichi" sort="Sakamoto, Seiichi" uniqKey="Sakamoto S" first="Seiichi" last="Sakamoto">Seiichi Sakamoto</name>
<affiliation><nlm:affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tanaka, Hiroyuki" sort="Tanaka, Hiroyuki" uniqKey="Tanaka H" first="Hiroyuki" last="Tanaka">Hiroyuki Tanaka</name>
<affiliation><nlm:affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morimoto, Satoshi" sort="Morimoto, Satoshi" uniqKey="Morimoto S" first="Satoshi" last="Morimoto">Satoshi Morimoto</name>
<affiliation><nlm:affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25815296</idno>
<idno type="pmid">25815296</idno>
<idno type="doi">10.3978/j.issn.2305-5839.2015.01.15</idno>
<idno type="wicri:Area/PubMed/Corpus">001660</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001660</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).</title>
<author><name sortKey="Sakamoto, Seiichi" sort="Sakamoto, Seiichi" uniqKey="Sakamoto S" first="Seiichi" last="Sakamoto">Seiichi Sakamoto</name>
<affiliation><nlm:affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tanaka, Hiroyuki" sort="Tanaka, Hiroyuki" uniqKey="Tanaka H" first="Hiroyuki" last="Tanaka">Hiroyuki Tanaka</name>
<affiliation><nlm:affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morimoto, Satoshi" sort="Morimoto, Satoshi" uniqKey="Morimoto S" first="Satoshi" last="Morimoto">Satoshi Morimoto</name>
<affiliation><nlm:affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of translational medicine</title>
<idno type="ISSN">2305-5839</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25815296</PMID>
<DateCompleted><Year>2015</Year>
<Month>03</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">2305-5839</ISSN>
<JournalIssue CitedMedium="Print"><Volume>3</Volume>
<Issue>3</Issue>
<PubDate><Year>2015</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Annals of translational medicine</Title>
<ISOAbbreviation>Ann Transl Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).</ArticleTitle>
<Pagination><MedlinePgn>35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2305-5839.2015.01.15</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakamoto</LastName>
<ForeName>Seiichi</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tanaka</LastName>
<ForeName>Hiroyuki</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Morimoto</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>China</Country>
<MedlineTA>Ann Transl Med</MedlineTA>
<NlmUniqueID>101617978</NlmUniqueID>
<ISSNLinking>2305-5839</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>12</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>12</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25815296</ArticleId>
<ArticleId IdType="doi">10.3978/j.issn.2305-5839.2015.01.15</ArticleId>
<ArticleId IdType="pii">atm-03-03-35</ArticleId>
<ArticleId IdType="pmc">PMC4356854</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Curr Opin Virol. 2014 Apr;5:58-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24584035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2013 Aug;23(8):986-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23835475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367 (19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2013 Oct;19(10 ):1313-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24013700</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2014 Apr 30;6(234):234ra59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24778414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1990 Aug 1;172(2):649-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2165129</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2006 Nov 11;368(9548):1696-705</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17098089</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2001 Apr 15;355(Pt 2):397-407</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11284727</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9960-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7937926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001660 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001660 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:25815296 |texte= Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV). }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25815296" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |